NeurologyLive Friday 5 — March 26, 2021

March 26, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 26, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Podcast: The Gaps in Migraine Care for Women

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Brian Grosberg, MD, about the results of a recently published study he and colleagues conducted that assessed the knowledge of women’s healthcare providers in the management of migraine in their patients.

2: Tweet Chat Highlights: MS Awareness Month

NeurologyLive cohosted a tweet chat with Barry Singer, MD, in honor of Multiple Sclerosis Awareness Month, featuring highlighted contributions from the medical community. Take a look at some of the highlights of the conversation.

3: NeuroVoices: Solomon Moshe, MD, and Elissa Yozawitz, MD, on Improving Neonatal Seizure Diagnosis

The duo from Montefiore Medical Center discussed a variety of topics surrounding an effort to improve seizure diagnosis and classification in newborns, the reasoning behind the sudden change in classification, and the need to do so for seizures in the neonate.

4: Cure Connections: Importance of Follow-Up Visits for SMA Amid COVID-19

Experts in spinal muscular atrophy (SMA) care, Diana Castro, MD, and Garey H Nortiz, MD, remind families of the importance of follow-up visits with the multidisciplinary team during COVID-19 for patients with SMA.

5: Understanding Chronic Inflammation in MS: Daniel Reich, MD, PhD

The senior investigator at the National Institutes of Neurological Disorders and Stroke outlined studies on anakinra and tolebrutinib as part of a new phase 2a clinical trial paradigm.

In Case You Missed It: Coverage of the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021 is still ongoing! To check back in to see the latest data presentations and interviews with investigators and opinion leaders, and more, click here.